Carlos Reding

102 Followers
146 Following
55 Posts

Microbial ecology, toy maths and drug resistance. DataSqueezer(TM): I turn coffee and coke into plots and hardware @Stanford now @BristolUni -> @NDMOxford

#Evolution #Microbiology #Genomics #DIY #Electronics #Modelling #SystemsBiology #Linux #Python #JuliaLang #FirstGen #PostDoc

Previous t00tshttps://scholar.social/@rc_reding
Websitehttps://www.sqrt2-microbe.org/
FraternityEpsilon Rho Rho
LocationOmicron Persei 9

Hi everyone 🖖

If you are thinkging about using #nanopore for genomic surveillance in #hospitals, but don't have the #bioinformatics nor command-line skills, don't let that put you off.

'Modernising Medical Microbiology', at @NDMOxford in #Oxford, has developed `OxBreaker': a graphical tool that can help identify budding #outbreaks by #healthcare professionals without having to upload your data to external servers and compromise patient privacy. Worth a read 👇

https://www.biorxiv.org/content/10.64898/2026.03.18.709804

OxBreaker: species-agnostic pipeline for the analysis of outbreaks using nanopore sequencing

Real-time genomic surveillance may mitigate the spread of health-care-associated infections, but whole-genome sequencing costs and the need for specialised expertise constrain its wide implementation in public health. Here we present ‘ OxBreaker ’, an automated and species-agnostic pipeline optimised for the high-resolution analysis of bacterial and plasmid genomes sequenced via Oxford Nanopore Technologies (ONT). ‘ OxBreaker ’ streamlines the transition from raw reads to phylogenetic inference through automated reference selection and high-accuracy variant calling. It is accessible via a graphical user interface (GUI) that can be easily installed locally and operated by non-specialists. Benchmarking against technical and biological replicates of high-priority pathogens demonstrates high accuracy, with false positive variant rates reduced to 0–4 single-nucleotide polymorphisms (SNPs) for common species. We further validated the pipeline by accurately characterising previously published clonal and plasmid-mediated outbreaks, reproducing established phylogenies with improved accessibility. By providing a stable, scalable, open-source offline-compatible solution that matches the resolution of short-read platforms while maintaining the speed of long-read technology, ‘ OxBreaker ’ is designed to facilitate the adoption of local, real-time genomic surveillance for frontline infection prevention and control. ### Competing Interest Statement The authors have declared no competing interest. NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, NIHR207397 NIHR Biomedical Research Centre, Oxford, GB

bioRxiv

Woah more than a year since I last posted.

Hello  

I walked into Oxford 

Techno in the Office

YouTube

2 x papers accepted between mid-Dec 2023 and mid-Jan 2024 (one as 1st author). And a sole-author paper that went through a double-hurdle to be reviewed at a fancy journal (which alone is worthy of some celebration on my end). What's in my mind (after frantically updating CV and notifying panels of the update*)?

https://www.youtube.com/shorts/ZIGZVSYoOz4

* Except those who said 'you cannot simply tell us you have two more papers'  and have my CV evaluated without my 2 now-accepted-publications.

Wellness Techno

YouTube

#Bioinformatics question for readers out here: A reviewer asked to put a quantitative metric to compare a software I wrote to analyse de novo assemblies vs reference-mapped assemblies...

Feels a bit like apples vs oranges (de novo vs reference-mapped) but the question is still there. And the number of genomes to process for this is 5,032.

Any suggestions?

Too many platforms to track, but... here's another #preprint  This is a tool I built to help my colleagues in Bristol vacuum info about any gene they wanted  Because they had phenotypic data on their stuff, they are using the tool to predict phenotypes from their genomic datasets. But that's another story.

It returns a spreadsheet w/ 1) mutations in CDS, 2) mutations in promoter, 3) relative copy number. I screened 5,000+ genomes to demo it.

https://www.biorxiv.org/content/10.1101/2023.09.15.557405

Postdocs in the academic [TT] market #PostdocLife

https://www.youtube.com/shorts/KhqmsAuJyCQ

Feeling Pressure

YouTube
I warn the audience, tho...

Next week I'll be presenting a poster of the pipeline I wrote. It's called Hound, and uses by default protein sequences to find AMR (and non-AMR) genes iteratively across thousands of de novoassemblies.

Given this, it was hard not to include "F--k the gene!" in the poster.

I'll show myself out now.

X: Carlos... can you run database ACME on all these isolates with your program?

Me: Of course, it's mean to give users flexibility for what they want---I said naively before checking ACME or the isolates.

X hands over a 2TB HDD.

Me: Blimey the Hound is slow today...

Then I proceed to checks server, ACME, and the isolates. So apparently I've been diggin' for more than 3,100 genes in 2,000 isolates